Cancer Treatment and Research Communications
Издатель: Elsevier · ISSN 2468-2942 · 85 статей
-
Rediscovering Kaposi Sarcoma in North Africa: Thirteen years of HIV-negative cases and survival insights from Morocco
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Khaoula Oussama, Bouchra Baghad, Sara Missaoui, Jalila El bakkouri, Ibtihal Benhsaien, Fatima Ailal, Ahmed Aziz Bousfiha, Soumiya Chiheb
-
Rethinking cardiovascular risk stratification in TKI-treated chronic myeloid leukemia
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Elena-Mihaela Cordeanu, Franck Zheng, Shanti Ame, Dominique Stephan
-
Hereditary cancer syndromes as a model for precision oncology: the paradigms of HRD and MSI
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Chiara Della Pepa, Alessia Mignano, Marialaura Zitiello, Laura Pesce, Gemma Caliendo, Marianna Stilo, Maria Teresa Vietri
-
Elevated expression of olfactory receptor 51T1 is associated with malignant potential of bladder cancer
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Taku Mochizuki, Yukari Ishiguro, Teppei Takeshima, Akihito Hashizume, Daiki Ueno, Masanobu Yamazaki, Yasuhide Miyoshi, Kazuhide Makiyama,...
-
Pleural metastasis of bone and soft tissue sarcomas: A review
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): YuanYou Yang, Lu Xie, Xin Sun, Jie Xu, Gang Ren
-
Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Chikashi Iwasaki, Eisaku Miyauchi, Takaya Yamamoto, Hisashi Tanaka, Yasuhito Nunomura, Yoshiomi Hatayama, Ryo Morita, Shin Fukui,...
-
Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade ≥3 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Shwan Ramadhan Ali, Dlzar Dlshad Ghafoor
-
Global, G20, and China burden of malignant neoplasms of bone and articular cartilage from 1990 to 2050: trends, projections, and ecological associations with healthcare expenditure
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Kun Dou, Qiang Ren, Jun Zhao
-
Association of neoadjuvant radiotherapy with 10-year survival outcomes in large cell lung cancer: A retrospective SEER-based study
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Yang Zhang, Lang Su, Yuchen Chang, Yanli Cai, Kelin Hong
-
Prognostic impact of residual viable tumor percentage on non-small cell lung cancer recurrence after neoadjuvant immunochemotherapy
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Ruihe Liu, Shenhua Liang, Jiayuan Tian, Yitao Yang, Xingyu Luo, Guowei Ma
-
Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Fatemeh Shakki Katouli, Fahimeh Zeinalkhani, Mohammad Hossein Hashemi, Fatemeh Nili, Rana Karimi, Reihaneh Mortazavi Ardestani, Elahe...
-
The prognostic value of HER2 in gastroesophageal adenocarcinoma – a meta-analysis
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Kristian Egebjerg, Jan Trøst Jørgensen, Michael Charles Sachs, Morten Mau-Sørensen
-
Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer–a Taiwanese multicenter cohort study
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Chien-Yu Chen, Ya-Chin Hou, Ying-Jui Chao, Na-Ning Kan, Ming-Hung Wang, Yueh-Wei Liu, Yu-Hung Lin, Chih-Jung Wang, Chien-Jui Huang,...
-
Increased abdominal visceral adipose tissue (VAT) in patients with metastatic lung adenocarcinoma under ALK inhibitors is associated with prolonged progression-free survival
Publication date: Available online 18 November 2026 Source: Cancer Treatment and Research Communications Author(s): Alice Baggi, Alessandro Monti, Luca Carlofrancesco Ammoni, Paolo Rondi, Filippo Morocutti, Deborah Cosentini, Giorgia...
-
Unmet Needs, Quality of Life, and Lived Experiences of Patients with Metastatic Breast Cancer in Central Vietnam: A Convergent Mixed-Methods Study
Publication date: Available online 19 November 2026 Source: Cancer Treatment and Research Communications Author(s): Minh Tri Phan, Ngoc Thanh Van Duong, Cao Khoa Dang, Phuc Thanh Nhan Nguyen, Thien Long Phan, Buu Ha Tran, Manh Hung...
-
Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lung cancer patients receiving active anticancer treatment: an observational study with prospective survival follow-up
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Sum-Yi Wong, Sum-Yin Chan, Sik-Kwan Chan, Tin-Ching Chau, Yiu-Ho Tam, Jasper Fuk Woo Chan, Chun-Yat Ip, Horace Cheuk-Wai Choi, Sherry...
-
Immunotherapy and circulating tumor DNA in HPV-positive oropharyngeal cancer: a systematic review and exploratory meta-analysis of survival and surveillance outcomes
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Mohammad Mahmoud Aouf, László Tamás, Hussein A. El-Shirbeny, Mohamed Abdel-Maboud, Kornél Dános
-
Female breast and gynecological cancers in Asia, 1990–2021: Burden and trends from the global burden of disease study
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Zohreh Gheisari, Manthar Ali Mallah, Jicun Zhu, Zihan Wang, Chensu Yang, Qian Yang, Donglin Jiang, Peng Wang, Jianxiang Shi, Mostafa...
-
CAD potentially mediates 5‑fluorouracil resistance in gastric cancer cells via modulation of uridine monophosphate synthetase expression
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Yixin Yang, Na Zhao, Yang Zhang, Jisheng Xie, Yaowen Zhang
-
Emerging immunotherapies in melanoma beyond immune checkpoint inhibitors: Vaccines, intralesional therapies, adoptive cell therapies, and T-cell engagers
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Ida Taglialatela, Leonardo Di Corcia, Andrea Boutros, Alice Gatti, Andrea Sponghini, Elia Esposto, Pamela Farinelli, Roberto Giorgione,...
-
Age-related early mortality and competing-risk outcomes in angioimmunoblastic T-cell lymphoma: a SEER-based population study
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Yingdan Huang, Chang Xue, Hao Lei, Huijing Wu
-
Effect of electromagnetic waves from doxorubicin on breast cancer growth in a mouse model
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Fuad H. Al-Ghamdi, Sara Abou Al-Saud, Hessah F AlShammari, Lama Binobaid, Rashed Almousa
-
Microbiota modulation in colorectal cancer: A scoping review of its potential role in toxicity mitigation and treatment response
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Daniel Rizky, Adriyan Pramono, Budi Setiawan, Eko Adhi Pangarsa, Damai Santosa, Catharina Suharti
-
Solasodine-derived steroidal alkaloids as dual modulators of PI3K/Akt signaling and metabolic reprogramming in breast cancer
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Precious Idakwoji, Ijeoma Nwafor, Claribel Okorie, Favor Udoeyop, Mannir Abubakar, Uzuazokaro Agatemor, Shehu Ali Auwal, Vitalis Ezeizu,...
-
Interpretable CT-based radiomics nomogram integrating clinical and semantic features for preoperative grading of pancreatic neuroendocrine neoplasms: a shap-based analysis
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Jia-Bei Liu, Cheng Tang, Ming-Rui Yang, Yi-Xun Li, Rong Kong, Qian Guo, Zi-Ning Lyu, Ying Liu, Peng Peng
-
Real-world analysis of treatments, healthcare costs, and overall survival among patients with metastatic non-small cell lung cancer by molecular biomarker testing approach
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Julie A. Wiedower, Karen M. Stockl, Jamie Tucker, Shaun P. Forbes, Nicole Zhang, Keelia Clemens, Julia M. Certa, Pamela Morin, Lucy Langer
-
Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Raquel P. Saraiva, Tamara J. Huizer, Bas P.L. Wijnhoven, Sjoerd M. Lagarde, Lindsey Oudijk, Bianca Mostert
-
Clinical response rates and adverse events associated with therapeutic tumor vaccines in lymphoma: A systematic review
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Alireza Ghasemi, Mohammadreza Ghasemi, Mohammadreza Heidari, Saghar Hoseinzadeh, Maryam Samareh Salavatipour, Shirin Tavakoli, Shima...
-
Psychological determinants of pain, fatigue, and symptom burden in breast cancer survivorship
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Nigora Madaminova, Nurova Shokhsanam, Rabbimova Dilfuza, Sulaymanova Dildora, Isakov Shuxrat, Musayeva Dilfuza, Kurbanova Gulnoz,...
-
Guardians of the germline, drivers of malignancy: piRNA-associated proteins as shared epigenetic regulators of infertility and cancer
Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Hajar Eftekhari, Soudeh Ghafouri-Fard